Indian Journal of Clinical and Experimental Ophthalmology
  • Year: 2018
  • Volume: 4
  • Issue: 2

Neuromyelitis optica-A masquerade of multiple sclerosis

  • Author:
  • Kambam Gainathi1,, Elfride Farokh Sanjana2, Hannah Ranjee Prasanth3
  • Total Page Count: 3
  • Page Number: 287 to 289

1Post Graduate, Dept. of Ophthalmology, Pondicherry Institute of Medical Sciences, Pondicherry, India

2Professor & HOD, Dept. of Ophthalmology, Pondicherry Institute of Medical Sciences, Pondicherry, India

3Associate Professor, Dept. of Ophthalmology, Pondicherry Institute of Medical Sciences, Pondicherry, India

*Corresponding Author: Email: gainathireddy@gmail.com

Online published on 24 September, 2018.

Abstract

We describe a case of neuromyelitis optica-a Masquerade of multiple sclerosis. Neuromyelitis optica should be differentiated from multiple sclerosis, as treatment of multiple sclerosis can worsen symptoms of neuromyelitis optica. Both visual and neurological prognosis in neuromyelitis optica are poorer than in multiple sclerosis. Episodes of visual loss in neuromyelitis optica are recurrent leading to severe visual impairment. Immunosuppressive agents such as corticosteroids remain the mainstay of therapy for acute episodes.

Keywords

Aquaporin-4, Azathioprine, Multiple sclerosis, MRI, Neuromyelitis optica